Sleep Disorders Clinical Trial
Official title:
Sleep Specialty Consultation: Improving Management of Sleep Disorders
Sleep disorders are prevalent health problems that reduce quality of life, increase risks for medical disease, and enhance healthcare costs/utilization. Only a small proportion of these cases are diagnosed in primary care. Pilot data from this VA suggest that sleep disorders are not adequately managed in a primary care setting: 33% of veterans with an insomnia complaint had an undiagnosed primary sleep disorder (e.g., sleep apnea), and 50% of these patients were prescribed pharmacologic treatment for insomnia by their primary care providers.
Sleep disorders are prevalent health problems that reduce quality of life, increase risks
for medical disease, and enhance healthcare costs/utilization. Only a small proportion of
these cases are diagnosed in primary care. Pilot data from this VA suggest that sleep
disorders are not adequately managed in a primary care setting: 33% of veterans with an
insomnia complaint had an undiagnosed primary sleep disorder (e.g., sleep apnea), and 50% of
these patients were prescribed pharmacologic treatment for insomnia by their primary care
providers. This project tests the incremental benefits of adding a one-time sleep specialty
consultation (SSC) to usual primary care for reducing sleep disturbance, diurnal
dysfunction, quality of life concerns and health care utilization among veterans enrolled in
the DVAMC Primary Care Clinics. The SSC will consist of: (1) a thorough sleep disorders
evaluation accomplished via a clinician-administered structured interview designed to assess
specific symptoms of global sleep disorder categories, review of a sleep history
questionnaire, and review of available (CPRS) medical/psychiatric electronic records; (2)
education about the specific sleep disorders diagnoses and relevant treatment
recommendations provided to the patients; and (3) standardized diagnostic information and
treatment recommendations provided to the participants' primary care providers. Study
hypotheses predict that patients who receive an SSC with feedback to their primary care
providers will show greater improvements in sleep, mood, quality of life, and patient
satisfaction, as well as larger reductions in health care utilization than will those who
receive usual care alone. This is a randomized, wait-list control, clinical intervention
study of 300 veterans with sleep complaints. Eligibility criteria include: sleep complaint
for > 1 month duration, Pittsburgh Sleep Quality Index score > 5; mental status score > 24
on Folstein MMSE, no unstable medical or psychiatric disorder, and approval of primary
provider. The SSC intervention consists of a clinician-administered structured interview
assessing sleep pathology, plus manualized feedback to patients and primary care providers.
Participants are randomly assigned to SSC or Wait List Control (WLC) conditions. Measures of
sleep, mood, quality of life, and patient satisfaction are obtained at enrollment and at 5-
and 10-month follow-up. Computerized utilization data is obtained for the 10 months prior to
and 10 months following enrollment. A series of multivariate and univariate statistical
tests will be conducted.
Study findings should provide important new information about managing both the sleep
problems and overall health care utilization patterns of patients with sleep complaints
presenting in VA primary care settings. If SSC-evaluated patients show substantial
reductions in their VA inpatient/outpatient utilization, this finding could have important
cost-saving implications to the VA system.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02188498 -
Electrocardiography Data Analysis in Sleep Disorders
|
||
Completed |
NCT00990106 -
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00942253 -
Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)
|
Phase 2 | |
Completed |
NCT00163670 -
The Impact of Sleep Disorders on Motor Vehicle Accidents
|
N/A | |
Completed |
NCT00256685 -
Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
|
Phase 3 | |
Completed |
NCT00203827 -
Pediatric Sleep Questionnaire: Use for Collection of Clinical Data
|
N/A | |
Completed |
NCT00174174 -
Provigil (Modafinil) Study by Taiwan Biotech Co.
|
N/A | |
Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
Completed |
NCT02939586 -
The Effect of Haemodialysis in Sleep Apnoea
|
N/A | |
Completed |
NCT03075241 -
Z-Drugs for Sleep Disorders in Alzheimer's Disease
|
Phase 3 | |
Completed |
NCT03055156 -
Effect of High Rebound Mattress Toppers on Sleep and Sleep-Related Symptoms
|
N/A | |
Completed |
NCT02585609 -
Sleep Quality in Patients With Advanced Cancer
|
N/A | |
Completed |
NCT01929447 -
Evaluation of WP200 With the Unified Probe (WP200U)
|
N/A | |
Completed |
NCT02156128 -
Subjective Memory Complaints, Objective Memory Performance and Cognitive Training
|
N/A | |
Completed |
NCT01906866 -
Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
|
Phase 3 | |
Completed |
NCT01528462 -
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
|
||
Completed |
NCT01256983 -
Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation
|
Phase 0 | |
Completed |
NCT01220401 -
Efficacy of a Brief Nightmare Treatment for Veterans
|
N/A | |
Not yet recruiting |
NCT00749814 -
Sleep Disturbances in Hospitalized Children
|
Phase 4 | |
Completed |
NCT00518986 -
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
|
Phase 4 |